From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Versarien & the £6m fund raise which provides not a cent upfront & will raise nothing like £6m - Ricketts lies about cash again

By Tom Winnifrith, The Sheriff of AIM | Monday 23 March 2020


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Versarien (VRS) this morning announced “subscription to raise £6 million”. Folks looked at the headline and the shares soared to 31p. Ha! Mugged by Ricketts again! Then they read the release. It is bullshit. Death spiral provider Lanstead is not putting up a cent up front and the total amount handed to Neill Ricketts’ bag of shite company over the next two years could well be well below its monthly cashburn! Ricketts really is the most shameless bullshitter and only scumbags like SP Angel, who took over as Nomad after Canaccord resigned, would sign off on such misleading gibberish which contains one MONSTER lie.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:32:34